Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 7Ocrevus

02 2Ocrevus Royalties

PharmaCompass

01

Brand Name : Ocrevus Royalties

Ocrelizumab

arrow
Pharmtech & Ingredients
Not Confirmed

Brand Name : Ocrevus Royalties

arrow
Pharmtech & Ingredients
Not Confirmed

Ocrelizumab

Main Therapeutic Indication : CNS & Anesthesia

Currency : USD

2020 Revenue in Millions : 845

2019 Revenue in Millions : 688

Growth (%) : 23

blank

02

Brand Name : Ocrevus

Ocrelizumab

arrow
Pharmtech & Ingredients
Not Confirmed

Brand Name : Ocrevus

arrow
Pharmtech & Ingredients
Not Confirmed

Ocrelizumab

Main Therapeutic Indication : CNS & Anesthesia

Currency : USD

2019 Revenue in Millions : 3,819

2018 Revenue in Millions : 2,424

Growth (%) : 58

blank

03

Brand Name : Ocrevus

Ocrelizumab

arrow
Pharmtech & Ingredients
Not Confirmed

Brand Name : Ocrevus

arrow
Pharmtech & Ingredients
Not Confirmed

Ocrelizumab

Main Therapeutic Indication : CNS & Anesthesia

Currency : USD

2020 Revenue in Millions : 4,820

2019 Revenue in Millions : 4,131

Growth (%) : 17

blank

04

Brand Name : Ocrevus

Ocrelizumab

arrow
Pharmtech & Ingredients
Not Confirmed

Brand Name : Ocrevus

arrow
Pharmtech & Ingredients
Not Confirmed

Ocrelizumab

Main Therapeutic Indication : Neurology

Currency : USD

2021 Revenue in Millions : 5,440

2020 Revenue in Millions : 4,586

Growth (%) : 17

blank

05

Brand Name : Ocrevus

Ocrelizumab

arrow
Pharmtech & Ingredients
Not Confirmed

Brand Name : Ocrevus

arrow
Pharmtech & Ingredients
Not Confirmed

Ocrelizumab

Main Therapeutic Indication : Neurology

Currency : USD

2022 Revenue in Millions : 6,598

2021 Revenue in Millions : 5,440

Growth (%) : 21

blank

06

Brand Name : Ocrevus

Ocrelizumab

arrow
Pharmtech & Ingredients
Not Confirmed

Brand Name : Ocrevus

arrow
Pharmtech & Ingredients
Not Confirmed

Ocrelizumab

Main Therapeutic Indication : Neurology

Currency : USD

2023 Revenue in Millions : 7,403

2022 Revenue in Millions : 6,598

Growth (%) : 6

blank

07

Brand Name : Ocrevus Royalties

Ocrelizumab

arrow
Pharmtech & Ingredients
Not Confirmed

Brand Name : Ocrevus Royalties

arrow
Pharmtech & Ingredients
Not Confirmed

Ocrelizumab

Main Therapeutic Indication : CNS & Anesthesia

Currency : USD

2019 Revenue in Millions : 688

2018 Revenue in Millions : 478

Growth (%) : 44

blank

08

Brand Name : Ocrevus

Ocrelizumab

arrow
Pharmtech & Ingredients
Not Confirmed

Brand Name : Ocrevus

arrow
Pharmtech & Ingredients
Not Confirmed

Ocrelizumab

Main Therapeutic Indication : Neurological/Mental Disorders

Currency : USD

2017 Revenue in Millions : 921

2016 Revenue in Millions : 0

Growth (%) : New Launch

blank

09

Brand Name : Ocrevus

Ocrelizumab

arrow
Pharmtech & Ingredients
Not Confirmed

Brand Name : Ocrevus

arrow
Pharmtech & Ingredients
Not Confirmed

Ocrelizumab

Main Therapeutic Indication : Neurological/Mental Disorders

Currency : USD

2018 Revenue in Millions : 2,377

2017 Revenue in Millions : 878

Growth (%) : 171%

blank